BioAffinity Cost Of Revenue from 2010 to 2024
| BIAFW Stock | USD 0.60 0.03 5.26% |
Cost Of Revenue | First Reported 2010-12-31 | Previous Quarter 1.7 M | Current Value 1.8 M | Quarterly Volatility 616.6 K |
Check BioAffinity Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioAffinity Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 262.1 K, Interest Expense of 35.3 K or Gross Profit of 831.2 K, as well as many indicators such as Price To Sales Ratio of 4.82, Dividend Yield of 0.0 or PTB Ratio of 2.78. BioAffinity financial statements analysis is a perfect complement when working with BioAffinity Technologies Valuation or Volatility modules.
BioAffinity | Cost Of Revenue |
Latest BioAffinity Technologies' Cost Of Revenue Growth Pattern
Below is the plot of the Cost Of Revenue of bioAffinity Technologies Warrant over the last few years. Cost of Revenue is found on BioAffinity Technologies income statement and represents the costs associated with goods and services BioAffinity Technologies provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is BioAffinity Technologies' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioAffinity Technologies' overall financial position and show how it may be relating to other accounts over time.
| Cost Of Revenue | 10 Years Trend |
|
Cost Of Revenue |
| Timeline |
BioAffinity Cost Of Revenue Regression Statistics
| Arithmetic Mean | 266,608 | |
| Geometric Mean | 41,385 | |
| Coefficient Of Variation | 231.27 | |
| Mean Deviation | 404,746 | |
| Median | 40,278 | |
| Standard Deviation | 616,589 | |
| Sample Variance | 380.2B | |
| Range | 1.8M | |
| R-Value | 0.58 | |
| Mean Square Error | 272.5B | |
| R-Squared | 0.33 | |
| Significance | 0.02 | |
| Slope | 79,722 | |
| Total Sum of Squares | 5.3T |
BioAffinity Cost Of Revenue History
About BioAffinity Technologies Financial Statements
BioAffinity Technologies investors use historical fundamental indicators, such as BioAffinity Technologies' Cost Of Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioAffinity Technologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 1.7 M | 1.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioAffinity Stock Analysis
When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.